NCT04184622 ), and in SURPASS-2 it outperformed semaglutide on glucose and weight endpoints in type 2 diabetes ( Fras et al., NEJM 2021 )
CJC-1295 DAC is a synthetic modified analog of Growth Hormone Releasing Hormone (GHRH) with a Drug Affinity Complex (DAC) modification, supplied for qualified laboratory research use
Optimise general joint health through evidence-based lifestyle measures: Maintain a healthy weight to reduce mechanical stress on weight-bearing joints Engage in regular low-impact exercise such as swimming, cycling, or walking to maintain joint mobility and strengthen supporting muscles Apply heat or cold therapy as appropriateheat for stiffness, cold for acute inflammation Follow a balanced diet with plenty of fruits, vegetables, and whole grains
Same attention to stability, same focus on letting the active ingredient do its job
Additionally, ELISA was performed to quantify secreted IL-6 and TGF- in co-culture media [2]